Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer Agaoglu, Ahmet Burak; Erdogan, Atike Pinar; Ekinci, Ferhat; Sahbazlar, Mustafa; Tekustun, Guler Nur; Tanriverdi, Ozgur; Tunbekici, Salih; Goker, Erdem; Akarca, Mehmet Sinan; Cangur, Can; Guclu Kantar, Taliha; Biter, Sedat; Bayram, Ertugrul; Colak, Gokhan; Demir, Bilgin; Basir, Hasan; Ercolak, Vehbi Share Save
Share Save
Share Save
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group Sahin, Gokhan; Tuzun, Esmanur Kaplan; Guzel, Halil G.; Guliyev, Murad; Disli, Ahmet K.; Yazici, Melike; Yildiz, Oguzhan; Gunes, Tugce K.; Alkan, Suleyman; Kahraman, Emir G.; Ozel, Gamze Serin; Icli, Mehmet C.; Sahin, Elif; Muglu, Harun; Acar, Caner; Tunbekici, Salih; Yuksel, Haydar C.; Yucel, Hakan; Kahya, Burcu Ulas; Kitapli, Sait; Buyuksimsek, Mahmut; Ipek, Suheda A.; Dama, Pinar E.; Usta, Ekin Akyildiz; Yilmaz, Mesut; Asik, Esra; Ozalp, Faruk R.; Savsar, Mehmet G.; Kocaaslan, Erkam; Sim, Saadet; Agaoglu, Ahmet B.; Camoz, Elif Sertesen; Demir, Teyfik; Uyar, Galip C.; Yildirim, Atila; Cinkir, Havva Y.; Salim, Derya Kivrak; Dogu, Gamze Gokoz; Alan, Ozkan; Bayram, Ertugrul; Karacin, Cengiz; Guc, Zeynep G.; Ekinci, Ferhat; Eryilmaz, Melek Karakurt; Semiz, Huseyin S.; Unal, Olcun U.; Goksu, Sema Sezgin; Ozturk, Banu; Inanc, Mevlude; Uygun, Kazim; Hacibekiroglu, Ilhan; Ercolak, Vehbi; Kara, Ismail O.; Yazici, Ozan; Bilici, Ahmet; Tanriverdi, Ozgur; Karaca, Burcak; Erman, Mustafa; Gokmen, Erhan; Goker, Erdem; Yildirim, Hasan Cagri Share Save
Share Save
Caffeic acid phenethyl ester (CAPE) Chitosan capped ZnO nanoparticles: Preparation, characterization, and its potential for the treatment of prostate cancer Ince, Iskender; Yildirim, Yeliz; Goker, Erdem; Guler, Gunnur; Saltan, Fehmi; Acar, Riza; Gumustas, Baris; Medine, E. Ilker Share Save
Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen mRNA vaccine BNT116+docetaxel in patients with advanced non-small cell lung cancer Oven, Bala Basak; Baz, David Vicente; Wolf, Jurgen; Ates, Ozturk; Goker, Erdem; Bruck, Patrick; Wenger, Michael; Munshi, Neru; Tsyhankova, Iryna; Tsyhankova, Iryna; Kaczorowska, Malgorzata; Schell, Thomas; Markman, Janet L.; Yang, Huyuan; Tureci, Ozlem; Sahin, Ugur; Forde, Patrick; Atmaca, Akin Share Save